Market Research Report - 117624
Global Markets for Infectious Disease Treatments
|Published by||BCC Research|
|Published||Content info||183 Pages|
Infectious diseases are one of the major causes of global morbidity and mortality. Viral, bacterial, parasitic and fungal diseases have plagued humankind for centuries, and our attempts to control these diseases have met with great success. Diseases that were once death sentences are now chronic and manageable diseases.
But as with every ongoing story, microbes have transformed themselves to outwit current medications, and the battle to rid humans of the most virulent of diseases continues. With the constant combining and reinvention of microbes comes an urgent need for improved antibiotic and viral medications to sustain the progress made in addressing the most aggressive of infectious diseases.
Under these circumstances, there is need for a current and comprehensive report on infectious diseases covering diagnosis, treatment, demand trends, opportunities, and emerging technologies.
This study gives a clear, quantitative picture of the supply-and-demand scenario, and it highlights the technological and investment opportunities in the field.
This report provides the reader with a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS]; hepatitis A, B, C; malaria, rotavirus/diarrhea; measles; pneumonia; and tuberculosis [TB]).
The report also discusses technological developments, future trends, and emerging opportunities. The major objectives of this study are:
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.
This updated version on the infectious disease market and technologies will be a valuable tool for decision makers and manufacturers in both the diagnostic and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies, and university laboratories will find valuable information on the global diagnostic product and pharmaceutical industries. This information will also be useful for individuals involved in strategic planning and marketing and sales development.
The audience will obtain a broad view of the social and economic consequences of infectious diseases. Additionally, emphasis on the type of disease, major players in the marketplace, market conditions, and current and projected revenues will be provided.
The data for this report were gathered from primary and secondary sources. Sources include information obtained from industry analysis, manufacturers, academic and trade journals, and industry associations. Additional sources include the U.S. Patent and Trademark Office (USPTO), U.S. Securities and Exchange Commission (SEC) filings, the World Health Organization (WHO), the Centers for Disease Control (CDC), the Mayo Clinic, the Pharmaceutical Research and Manufacturing Association, and UNAIDS.
Where precise information was not available, a projection was made using reasonable assumptions and estimates based on historical data. All market data are based on manufacturers' sales.
Peggy Lehr is the BCC Research analyst for this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked as a researcher, editor, and publisher within the publishing industry for both for-profit and not-for-profit organizations. She is the author of several BCC reports dealing with healthcare, pharmaceuticals, and agriculture.